Paper28097809
Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Zhang A and 7 others. Cancer Med, 2017. Cited by 182 papers, by iCite.
Cite this record
ConductScience Library. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Papers, record 28097809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28097809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer-Associated Fibroblasts | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Macrophage Colony-Stimulating Factor | Major topic |
| Macrophages | Major topic |
| Pancreatic Neoplasms | Major topic |
| Antigens, CD | |
| Antigens, Differentiation, Myelomonocytic | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Polarity | |
| Cell Proliferation | |
| Coculture Techniques | |
| Culture Media, Conditioned | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Lectins, C-Type | |
| Mannose Receptor | |
| Mannose-Binding Lectins | |
| Receptors, Cell Surface | |
| Tumor Cells, Cultured | |
| Tumor Microenvironment | |
| CD163 Antigen |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24856586 | Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24856586 | PubMed |
| 2 | 25082815 | CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. | Cancer Res | 2014 | https://conductscience.org/library/papers/25082815 | PubMed |
| 3 | 19428556 | Role of macrophages in tumour progression. | Immunol Lett | 2009 | https://conductscience.org/library/papers/19428556 | PubMed |
| 4 | 25559415 | Cancer statistics, 2015. | CA Cancer J Clin | 2015 | https://conductscience.org/library/papers/25559415 | PubMed |
| 5 | 24100343 | M-CSF cooperating with NFκB induces macrophage transformation from M1 to M2 by upregulating c-Jun. | Cancer Biol Ther | 2014 | https://conductscience.org/library/papers/24100343 | PubMed |
| 6 | 22287548 | Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. | Cancer Res | 2012 | https://conductscience.org/library/papers/22287548 | PubMed |
| 7 | 18829522 | Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. | Cancer Res | 2008 | https://conductscience.org/library/papers/18829522 | PubMed |
| 8 | 25024225 | Stromal response to Hedgehog signaling restrains pancreatic cancer progression. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25024225 | PubMed |
| 9 | 24315741 | Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. | Cancer Treat Rev | 2014 | https://conductscience.org/library/papers/24315741 | PubMed |
| 10 | 24277834 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24277834 | PubMed |
| 11 | 19460966 | Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. | Science | 2009 | https://conductscience.org/library/papers/19460966 | PubMed |
| 12 | 24856585 | Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24856585 | PubMed |
| 13 | 18245495 | Cancer-associated stromal fibroblasts promote pancreatic tumor progression. | Cancer Res | 2008 | https://conductscience.org/library/papers/18245495 | PubMed |
| 14 | 21734707 | Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. | Nature | 2011 | https://conductscience.org/library/papers/21734707 | PubMed |
| 15 | 15166270 | Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. | J Clin Pathol | 2004 | https://conductscience.org/library/papers/15166270 | PubMed |
| 16 | 23514705 | Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. | Cancer Res | 2013 | https://conductscience.org/library/papers/23514705 | PubMed |
| 17 | 23752925 | ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. | Cell Res | 2013 | https://conductscience.org/library/papers/23752925 | PubMed |
| 18 | 22698407 | Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. | Cancer Cell | 2012 | https://conductscience.org/library/papers/22698407 | PubMed |
| 19 | 24406209 | Regulation of the anti-tumour immune response by cancer-associated fibroblasts. | Semin Cancer Biol | 2014 | https://conductscience.org/library/papers/24406209 | PubMed |
| 20 | 17909062 | Dynamics of the immune reaction to pancreatic cancer from inception to invasion. | Cancer Res | 2007 | https://conductscience.org/library/papers/17909062 | PubMed |
Cited by143
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877588 | Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42877588 | PubMed |
| 42616191 | Biofabrication and artificial intelligence strategies for investigating solid- and fluid-pressure mechanobiology in pancreatic ductal adenocarcinoma. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42616191 | PubMed |
| 42550393 | Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42550393 | PubMed |
| 42432219 | Inhibiting CXCL12/CXCR4 axis enhances T cell activity in gastric cancer. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42432219 | PubMed |
| 42332796 | Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. | BMC Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42332796 | PubMed |
| 42190018 | Oxidative stress and serum deprivation influence the evolution of newly formed tetraploid cells during tumorigenesis. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42190018 | PubMed |
| 42174633 | Nanomaterials targeting cancer-associated fibroblasts to overcome stromal barriers in cancer immunotherapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42174633 | PubMed |
| 42071201 | Cytokines and cancer-associated fibroblasts. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42071201 | PubMed |
| 41688740 | Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/41688740 | PubMed |
| 41615586 | Identification and validation of an m1A-score model to predict outcomes and immunomodulation in lung squamous cell carcinoma by integrated analysis of single-cell and bulk RNA sequencing. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41615586 | PubMed |
| 41545706 | Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41545706 | PubMed |
| 41530855 | Immunological and molecular insights into acinar-ductal metaplasia and atypical flat lesions as precursor lesions of pancreatic ductal adenocarcinoma. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41530855 | PubMed |
| 41478978 | Macrophage Enhancement of Tumor Cell Extravasation and Intravasation In Vitro. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41478978 | PubMed |
| 41456229 | Single cell analysis reveals cancer associated fibroblast subtypes as prognostic markers and therapeutic targets in gastric cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41456229 | PubMed |
| 41441395 | Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy. | Tomography | 2025 | https://conductscience.org/library/papers/41441395 | PubMed |
| 41209618 | Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/41209618 | PubMed |
| 41152935 | Advances in engineering immune-tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41152935 | PubMed |
| 41150820 | The Tumor-Suppressive Role of SAT2 in Pancreatic Cancer: Involvement in PI3K/Akt-MAPK Pathways and Immune Modulation. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150820 | PubMed |
| 40855036 | Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40855036 | PubMed |
| 40757874 | CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40757874 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CD163 | 9332 | PubTator's text mining | https://conductscience.org/library/genes/9332 | NCBI Gene |
| CSF1 | 1435 | PubTator's text mining | https://conductscience.org/library/genes/1435 | NCBI Gene |
| CSF1R | 1436 | PubTator's text mining | https://conductscience.org/library/genes/1436 | NCBI Gene |
| CXCL12 | 6387 | PubTator's text mining | https://conductscience.org/library/genes/6387 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| KRT19 | 3880 | PubTator's text mining | https://conductscience.org/library/genes/3880 | NCBI Gene |
| MRC1 | 4360 | PubTator's text mining | https://conductscience.org/library/genes/4360 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28097809
GET https://conductscience.org/api/papers/v1/28097809/references?page=2